Browse/search for people

Dr Sebastian Oltean

Dr Sebastian Oltean

Dr Sebastian Oltean
MBBS (Cluj, Romania), PhD (Univ of Nebraska-Lincoln, USA)

Senior Lecturer

Office C39b
Dorothy Hodgkin Building,
Whitson Street, Bristol BS1 3NY
(See a map)

+44 (0) 117 3311468
+44 (0) 117 331 3165


My main research interests include the study of alternative splicing in vivo, coordinated regulation of alternative splicing in physiology and disease as well as manipulation of splice isoforms choice for therapeutic goals. Alternative splicing is the main process that decides the diversity of proteins in our bodies. It is estimated that more than 90% of genes are alternatively spliced in humans and therefore this process affects all cellular properties. The function of the majority of splicing isoforms is not characterized yet. Numerous splicing isoforms have been associated with disease progression in recent years and there is much interest in understanding their contribution to pathogenesis and how this can be reversed.


Sebastian studied clinical medicine at  “Iuliu Hatieganu” Medical School, Cluj-Napoca, Romania and trained as a junior doctor in Nephrology and Dialysis before moving to USA where he obtained a PhD from the University of Nebraska-Lincoln in 2004.This was followed by postdoctoral training at Duke University Medical Center (North Carolina, USA) where he became interested in studying the connections between alternative splicing and cancer. Using fluorescent splicing reporters that recapitulate in vivo the alternative splicing of fibroblast growth factor 2 and are able to follow epithelial-mesenchymal transitions he discovered unusual plasticity in prostate cancer cells in animal models. This was further followed by studies of circulating tumour cells from patients showing that the same plasticity is associated with aggressive prostate and breast cancer behavior. In 2008 he moved to the University of Bristol where he is now a principal investigator and continues to study alternative splicing in vivo, with focus towards the importance of several genes splice isoforms (e.g VEGF, FGFR2) in cancer as well as kidney diseases and development of splice-based therapeutics.


MSc in Biomedical Sciences Research - Cancer Biology Unit 2 - Angiogenesis in Cancer

MB ChB Programme - year 2 - Renal System

BSc Health Sciences - Cell fate / cancer

BSc - Pharmacology 2A


  • microcirculation
  • tumour biology
  • kidney pathology
  • fibrosis
  • alternative splicing
  • novel therapeutics


  • cancer (prostate cancer)
  • chronic kidney diseases (diabetic nephropathy)

Selected publications

Read more >

Recent publications

View complete publications list in the University of Bristol publications system

Edit this profile If you are Dr Sebastian Oltean, you can edit this page. Login required.

PDF versionDownload PDF